
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Invivyd
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Invivyd, Inc. (Nasdaq: IVVD) is a commercial-stage company is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases. Leveraging state-of-the-art viral surveillance, predictive modeling, and advanced antibody engineering techniques, we are taking a platform-based approach to the continuous discovery and optimization of monoclonal antibody candidates designed to protect the vulnerable from serious viral threats. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for its first mAb in a planned series of innovative antibody candidates. Visit https://invivyd.com/ to learn more
C-Level 0 | VP - Level- |
Director1 | Manager6 |
Others81 |
Pain Points | Locations | Technologies |
---|---|---|
Account Payable | Waltham, MA | sas, quality assurance, audit, compliance, j, analytics, communication, integrity, exchange, assessment, quality assurance quality control, visualization, payroll, collaboration, payment, packaging, hoc, gmp, sox, financial, e, sql, testing, forecasting, risk, measurement, continuous improvement, wire, operations |
Animation | Waltham, MA | communication, risk, video conferencing, protection |
Application Development | Phoenix, AZ | communication, compliance, financial, e, continuous improvement, operations |
Application Development | Waltham, MA | sas, quality assurance, compliance, audit, j, analytics, communication, integrity, exchange, assessment, quality assurance quality control, visualization, protection, payroll, collaboration, payment, video conferencing, packaging, hoc, gmp, sox, financial, e, sql, testing, forecasting, risk, measurement, continuous improvement, wire, operations |
BI | Waltham, MA | sas, quality assurance, compliance, audit, j, analytics, communication, integrity, exchange, assessment, quality assurance quality control, visualization, protection, payroll, collaboration, payment, video conferencing, packaging, hoc, gmp, sox, financial, sql, testing, e, forecasting, risk, measurement, continuous improvement, wire, operations |
Invivyd looking to hire in Database Administration in Los Angeles Metropolitan Area
Invivyd looking to hire in Database Administration in Nevada, United States
Invivyd looking to hire in Database Administration in Atlanta, GA
Collaborator
Gcp
Netsuite
Access
Acrobat
Analytics
Archival
Archiving
Assessment
Audit
ABOUT USInvivyd is on a mission to rapidly and perpetually deliver antibody-based therapies that ...
View MoreABOUT USInvivyd is on a mission to rapidly and perpetually deliver antibody-based therapies that ...
View MoreABOUT USInvivyd is on a mission to rapidly and perpetually deliver antibody-based therapies that ...
View MoreABOUT USInvivyd is on a mission to rapidly and perpetually deliver antibody-based therapies that ...
View MoreABOUT USInvivyd is on a mission to rapidly and perpetually deliver antibody-based therapies that ...
View MoreABOUT USInvivyd is on a mission to rapidly and perpetually deliver antibody-based therapies that ...
View MoreABOUT USInvivyd is on a mission to rapidly and perpetually deliver antibody-based therapies that ...
View MoreABOUT USInvivyd is on a mission to rapidly and perpetually deliver antibody-based therapies that ...
View MoreInvivyd, Inc. (Nasdaq: IVVD) is a commercial-stage company is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases. Leveraging state-of-the-art viral surveillance, predictive modeling, and advanced antibody engineering techniques, we are taking a platform-based approach to the continuous discovery and optimization of monoclonal antibody candidates designed to protect the vulnerable from serious viral threats. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for its first mAb in a planned series of innovative antibody candidates. Visit https://invivyd.com/ to learn more
Invivyd operates in the Biotechnology research industry.
Invivyd's revenue is 11m - 100m
Invivyd has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.